Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. - Wikidata - awgldk - TriplyDB

Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer.

Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer.

http://www.wikidata.org/entity/Q54255971

about

Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer Appraisal of needle-based confocal laser endomicroscopy in the diagnosis of pancreatic cysts Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Role of MicroRNAs-221/222 in Digestive Systems Multidisciplinary diagnostic and therapeutic approaches to pancreatic cystic lesions Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects microRNA biomarkers in cystic diseases.MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis.Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies.A microRNA meta-signature for pancreatic ductal adenocarcinoma.Systematic Review of Pancreatic Cyst Fluid Biomarkers: The Path Forward.Contribution of microRNA analysis to characterisation of pancreatic lesions: a review.Novel Biomarkers for Pancreatic Cysts.Mir-221/222 are promising targets for innovative anticancer therapy.Team work and cytopathology molecular diagnosis of solid pancreatic lesions.Endoscopic Management of Pancreatic Cysts.Pancreatic Cysts and Guidelines.Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.[Cystic pancreatic tumors: diagnostics and new biomarkers].

P2860

Q26749037-81745F39-D0D2-4079-98D5-A4C6632CF343 Q26765233-7A7B46B3-FE23-4345-B796-74ADD7735413 Q26773189-CD491D34-7DCA-4621-B07B-2AFE14F88D59 Q26774690-A9764E6F-4A09-40B7-AB9B-E05624AD5AEE Q26783953-E882A712-4A41-4013-AE51-8146BCE8DEA5 Q26799779-10F8B68E-7C4D-4078-B08E-B753ABB73707 Q26799877-1CC679E4-24E1-4499-AEBB-0AADAC6CCFCC Q26829835-FB9AD319-03C8-4D13-A9A0-E6D1E1B34EE7 Q28074465-B712F6CC-5615-4FC5-92EA-ED195FF8744E Q33668095-EF19B4E9-4EA2-49C7-9905-D59414A2FA4A Q33801377-20CA7646-C701-4311-9C24-8F20922DA568 Q34049572-18EA3DD2-C8E5-4A29-8FCB-029CBFD2B30A Q34093798-80FAA1C6-D2AB-448D-96BC-0AE8552002A1 Q35740184-968AFBCC-A429-4A7B-81DE-D646C0BB4013 Q37317608-A966841F-3C71-44F0-A378-EE06CD3F1F9C Q38191669-1BE51909-04BA-457E-A439-03516339AC9C Q38525151-E1BAC30D-DEAB-4D4E-B51E-CAB7D428B0B5 Q38575189-F5B41E9D-5320-4F59-A4C4-E6601DC56CA6 Q38757526-5218F344-012B-4E54-8EBD-043594B48ABA Q38767024-1A2F0D6A-FCDD-42E5-AA7C-7F0FC57EEF8E Q39132122-8310ABE0-6C6B-4919-9620-6D55CDC42528 Q39185564-24A794BA-D88E-4F29-92F6-DE1F0BD592AB Q39320253-FA914775-A2B0-4385-80D6-D25859049195 Q39390859-57B054DC-9027-48C9-A332-2430ECA18F40 Q47373659-8F453579-58AE-4BAB-A182-07053FD2D680 Q51820838-FCA31B38-76E3-449A-9162-2C660D95C67B Q53100266-42B39DA2-A017-43E0-BD73-A1EBE88F253D

P2860

Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer.

http://www.wikidata.org/entity/Q54255971

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Endoscopically acquired pancre ...... sociated with invasive cancer.

@en

Endoscopically acquired pancre ...... sociated with invasive cancer.

@nl

type

label

Endoscopically acquired pancre ...... sociated with invasive cancer.

@en

Endoscopically acquired pancre ...... sociated with invasive cancer.

@nl

prefLabel

Endoscopically acquired pancre ...... sociated with invasive cancer.

@en

Endoscopically acquired pancre ...... sociated with invasive cancer.

@nl

P1433

Q54255971-65219D70-1923-4123-BE32-0FA78B90161A

P1476

Q54255971-81AA4203-894D-4489-9871-A8108D86D042

P2093

Q54255971-0E001F3E-B9D5-4C93-84A0-4ABAA22F23EE

Q54255971-1B98418D-E57B-4622-87B8-9B5F3D2504C1

Q54255971-2B8B2FBE-5CBD-4A37-AC97-704EF5394B3A

Q54255971-42D84863-6D9F-4EE3-B64B-C4E9AD06A4FC

Q54255971-579AF46D-91E2-4D9B-886C-57AE766EE2BE

Q54255971-5ED96652-3B6A-4C07-A822-BA211F95216E

Q54255971-65F870DC-2D03-4124-A526-055F417A8EB5

Q54255971-8D014CA4-1AAE-4C4D-BF53-488630AAB610

Q54255971-D67E8900-4AE8-4785-9938-78F002538180

Q54255971-EC88E180-B9CA-4809-8635-0D273BAC22CD

P2860

Q54255971-065B5170-8389-4569-BE35-8FC7F6E5651A

Q54255971-088C7270-3230-492E-8A2C-1585A77B120B

Q54255971-11DD9DE4-1A30-45CD-ABF3-693AB3888179

Q54255971-2BF928C2-CC56-4F2A-A21A-6D0E7FCA5F48

Q54255971-2E5317B7-5B89-429E-98EA-42D6CEF712AF

Q54255971-3B8B7A16-4291-49DA-A6A0-E8F1086DD38A

Q54255971-3DB7A27D-3A11-496C-8FD8-D867F1695631

Q54255971-4603CE50-3CDA-43BA-AA5A-56D30C4B13F7

Q54255971-469C5279-110B-49F3-8EF5-92B77B3AD47E

Q54255971-49B08C63-F116-43E3-B0FA-482B623001CD

P304

Q54255971-30100147-2BD6-41EF-BA8A-E4505E89292F

P31

Q54255971-B7166906-38D3-4790-BF99-B1B10465A29F

P356

Q54255971-32652D79-376F-4312-80EC-2F62B43F3543

P407

Q54255971-443063C2-0980-46F0-A285-C80C8047B958

P433

Q54255971-3E577B46-1A2E-4350-BEA4-3BC8287F8F93

P478

Q54255971-D7822F59-1DCF-45A9-A180-370F033D3527

P577

Q54255971-2FD8D6DE-A0E9-4646-B03F-65EB67CBC71A

P5875

Q54255971-E227B96B-B467-4561-8EA1-FFDB3635C8AF

P698

Q54255971-0DA4AB84-B785-4FB8-8AE4-A448EFB5CB20

P921

Q54255971-A3A7513F-6ED6-4D7E-914E-7720A467AE47

P356

P1433

The American Journal of Gastroenterology

P1476

Endoscopically acquired pancre ...... sociated with invasive cancer.

@en

P2093

Daniel Malkhassian

http://www.w3.org/2001/XMLSchema#string

David Dawson

http://www.w3.org/2001/XMLSchema#string

Hong Wu

http://www.w3.org/2001/XMLSchema#string

James J Farrell

http://www.w3.org/2001/XMLSchema#string

Jonathan Wong

http://www.w3.org/2001/XMLSchema#string

Linh M Tran

http://www.w3.org/2001/XMLSchema#string

Luyi Li

http://www.w3.org/2001/XMLSchema#string

Nanping Wu

http://www.w3.org/2001/XMLSchema#string

Paul Toste

http://www.w3.org/2001/XMLSchema#string

Timothy R Donahue

http://www.w3.org/2001/XMLSchema#string

P2860

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms.

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.

Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.

P304

1352-1359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2013.167

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237097316

http://www.w3.org/2001/XMLSchema#string

P698

23752880

http://www.w3.org/2001/XMLSchema#string

P921